Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Zimmer Biomet (ZBH)

Zimmer Biomet Reports Third Quarter 2026 Results and Updates Full-Year Guidance

Mixed Impact 4 of 5 earnings

Zimmer Biomet Holdings, Inc. reported third quarter 2026 net sales of $2.063 billion, representing a 3.1% reported increase and a 3.7% increase on a constant currency basis. Diluted earnings per share were $1.00, down 13.8%, while adjusted diluted earnings per share were flat at $1.90. Following the broad-based performance, the company raised its full-year 2026 organic constant-currency revenue growth and adjusted EPS guidance.

Key points

  • Third quarter net sales reached $2.063 billion, up 3.1% on a reported basis.
  • Diluted earnings per share were $1.00, compared to $1.16 in the prior year period.
  • Adjusted diluted earnings per share were $1.90, matching the prior year period.
  • Full-year 2026 adjusted diluted EPS guidance was updated to a range of $8.50 to $8.60.

The filing

CompanyZimmer Biomet (ZBH)
Form8-K, current report
Filed with the SECNov 4, 2026, 6:30 AM ET
Accession number0001193125-26-446145

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 4, 2026, 8:16 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.